CYCCP - Cyclacel Pharmaceuticals Inc. (CYCC) CEO Spiro Rombotis on Q1 2022 Results - Earnings Call Transcript
Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2022 Earnings Conference Call May 11, 2022, 16:30 ET Company Participants Irina Koffler - LifeSci Advisors Spiro Rombotis - President, CEO & Executive Director Paul McBarron - EVP, CFO, COO, Secretary & Executive Director Mark Kirschbaum - SVP & Chief Medical Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Ahu Demir - Ladenburg Thalmann & Co. Jonathan Aschoff - ROTH Capital Partners Presentation Operator Good afternoon, and welcome to the Cyclacel Pharmaceuticals First Quarter 2022 Results Conference Call and Webcast. [Operator Instructions]. Please note, today's call is being recorded. I would now like to turn the conference call over to the company. Irina Koffler Good afternoon, everyone, and thank you for joining today's conference call to discuss Cyclacel's Financial Results and Business Highlights for the first quarter of 2022. Before turning the call over to management, I would like to remind everyone that during this
For further details see:
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2022 Results - Earnings Call Transcript